Jy. Fan et al., ANILINE MUSTARD ANALOGS OF THE DNA-INTERCALATING AGENT AMSACRINE - DNA INTERACTION AND BIOLOGICAL-ACTIVITY, Anti-cancer drug design, 12(3), 1997, pp. 181-203
Two series of analogues of the clinical antileukemic drug and DNA-inte
rcalating ligand amsacrine have been prepared, containing aniline must
ard sidechains of varying reactivity, linked either at the 4-position
of the intercalating acridine chromophore (type A) or at the 1'-positi
on of the 9-anilino group (type B). DNase I footprinting assays showed
that compounds of type B had stronger reversible binding to DNA. than
did compounds of type A. Compounds of each type showed similar patter
ns of alkylation-induced cleavage of DNA, and alkylate at the N7 of gu
anines in runs of guanines (similar to the pattern for untargeted must
ards) as well as some adenines. Both classes of compounds crosslinked
DNA, although those bearing relatively inactive mustards did so only a
t high drug/base pair ratios. However, while the patterns of DNA alkyl
ation were broadly similar, the compounds were considerably more cytot
oxic than analogous untargeted mustards. Comparison of their cytotoxic
ities in wild-type and DNA repair-deficient lines indicated this toxic
ity was due to DNA crosslinks (except for the least reactive SO2-linke
d mustards). The 4-linked analogues showed slightly higher in vivo ant
ileukemic activity than the corresponding 1'-linked analogues.